Additional value of interleukin-6 level to predict histopathological features of hepatocellular carcinoma before liver transplantation.
Fiche publication
Date publication
juin 2023
Journal
Cytokine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe
Tous les auteurs :
Paul C, Besch C, Artzner T, Michard B, Cusumano C, Addeo P, Bachellier P, Faitot F
Lien Pubmed
Résumé
Inflammatory biomarkers are increasingly used as outcome predictors in the field of oncology and liver transplantation for HCC, but no study has shown the prognostic value of IL6 after LT. The goal of this study was to evaluate the predictive value of IL-6 on histopathological features of HCC on explant, its predictive value on recurrence risk and its additional value to other scores and inflammatory markers at the time of transplantation.
Mots clés
Hepatocellular carcinoma, Inflammatory biomarkers, Interleukin 6, Liver transplantation, Recurrence, Transplant oncology
Référence
Cytokine. 2023 06 27;169:156286